Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors

Autor: Richard T. Maziarz, Dietger Niederwieser, Alois Gratwohl, Michael B. Maris, Barry E. Storer, Ed Agura, Benedetto Bruno, Brenda M. Sandmaier, Rainer Storb, Peter A. McSweeney, Judith A. Shizuru, Hildegard Greinix, Haifa Kathrin Al-Ali, Finn Bo Petersen, David Maloney, Thoralf Lange, Thomas R. Chauncey, U Hegenbart, Catherine Cordonnier, Bernard Rio

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 24(3)

Purpose The use of low-dose, irradiation-based preparative regimens have allowed the extension of allografting to older and medically infirm patients. The study reported here assessed outcomes for patients with acute myeloid leukemia (AML) in differe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4034c8d9c529f3cfe8e0dd05e193c3b3
https://pubmed.ncbi.nlm.nih.gov/16344316

Identification and sequence analysis of the promoter for the leukocyte integrin beta-subunit (CD18): a retinoic acid-inducible gene

Autor: ED Agura, M Howard, SJ Collins

Publikováno v: Blood. 79(3)

Leukocyte adhesion receptors (LFA-1; Mac-1; p150,95) are a family of heterodimeric cell-surface adhesion molecules expressed exclusively in granulocytes, lymphocytes, and macrophages. Expression of these proteins is under complex regulatory control,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e48e0a653c8a8b4d4551a0446425326
https://pubmed.ncbi.nlm.nih.gov/1346252

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades.

Autor: Cooper JP; Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA., Storer BE; Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA., Granot N; Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Gyurkocza B; Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA., Sorror ML; Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA., Chauncey TR; Fred Hucthinson Cancer Research Center, Univ of Washington, VA Puget Sound Health Care, Seattle, USA., Shizuru J; Stanford University, Palo Alto, CA, USA., Franke GN; University of Leipzig, Leipzig, Germany., Maris MB; Colorado Blood Cancer Institute at HealthONE Presbyterian/St. Luke Medical Center, Denver, USA., Boyer M; University of Utah, Salt Lake City, UT, USA., Bruno B; Azienda Ospedaliera S Giovanni Battista, University of Turin, Turin, Italy., Sahebi F; City of Hope/Kaiser Permanente Medical Group, Duarte, CA, USA., Langston AA; Winship Cancer Institute at Emory University, Atlanta, GA, USA., Hari P; Medical College of Wisconsin, Milwaukee, WI, USA., Agura ED; Baylor University, Dallas, TX, USA., Lykke Petersen S; University of Copenhagen Rigshospitalet, Copenhagen, Denmark., Maziarz RT; Oregon Health and Science University, Portland, OR, USA., Bethge W; Medical Center University of Tübingen, Tübingen, Germany., Asch J; LDS Hospital, Salt Lake City, UT, USA., Gutman JA; University of Colorado, Denver, CO, USA., Olesen G; Aarhus University, Aarhus, Denmark., Yeager AM; University of Arizona Cancer Center, Tucson, AZ, USA., Hübel K; University Hospital of Cologne, Cologne, Germany., Hogan WJ; Mayo Clinic, Rochester, MN, USA., Maloney DG; Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA., Mielcarek M; Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA., Martin PJ; Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA., Flowers MED; Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA., Georges GE; Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA., Woolfrey AE; Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA., Deeg JH; Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA., Scott BL; Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA., McDonald GB; Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA., Storb R; Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA., Sandmaier BM; Fred Hutchinson Cancer Research Center and the University of Washington, Seattle, WA, USA.

Publikováno v: Haematologica [Haematologica] 2021 Jun 01; Vol. 106 (6), pp. 1599-1607. Date of Electronic Publication: 2021 Jun 01.

Long-term sustained disease control in patients with mantle cell lymphoma with or without active disease after treatment with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning.

Autor: Vaughn JE; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington., Sorror ML; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington., Storer BE; Clinical Statistics Program, Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Department of Biostatistics, University of Washington School of Public Health, Seattle, Washington., Chauncey TR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.; Marrow Transplant Unit, VA Puget Sound Health Care System, Seattle, Washington., Pulsipher MA; Pediatric Blood and Marrow Transplant Program, Primary Children's Hospital, Salt Lake City, Utah.; Division of Hematology/Hematological Malignancies, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah., Maziarz RT; Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon., Maris MB; Colorado Blood Cancer Institute, Denver, Colorado., Hari P; Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin., Laport GG; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford School of Medicine, Stanford, California., Franke GN; Division of Hematology, Oncology, and Hemostaseology, Department of Medicine, University of Leipzig, Leipzig, Germany., Agura ED; Hematopoietic Stem Cell Program, Baylor University School of Medicine, Dallas, Texas., Langston AA; Division of Hematology-Oncology, Emory University School of Medicine, Atlanta, Georgia.; Bone Marrow & Stem Cell Transplant Center, Winship Cancer Institute, Emory University, Atlanta, Georgia., Rezvani AR; Division of Blood and Marrow Transplantation, Department of Medicine, Stanford School of Medicine, Stanford, California., Storb R; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington., Sandmaier BM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington., Maloney DG; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.; Division of Medical Oncology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington.

Publikováno v: Cancer [Cancer] 2015 Oct 15; Vol. 121 (20), pp. 3709-16. Date of Electronic Publication: 2015 Jul 24.

Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting.

Autor: Rotta M; Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA., Storer BE, Sahebi F, Shizuru JA, Bruno B, Lange T, Agura ED, McSweeney PA, Pulsipher MA, Hari P, Maziarz RT, Chauncey TR, Appelbaum FR, Sorror ML, Bensinger W, Sandmaier BM, Storb RF, Maloney DG

Publikováno v: Blood [Blood] 2009 Apr 02; Vol. 113 (14), pp. 3383-91. Date of Electronic Publication: 2008 Nov 17.